ERBB2 and neoplasm: Moreover, this overexpression can lead to a 100–200-fold increase in the concentration of the HER2 protein in a tumor compared to normal tissue [7,21,22], suggesting that HER2 can serve as a tumor-associated antigen (TAA) [21,23].